hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet
RxNorm concept 1050325, clinical drug (scd). Prescribable name: methenamine 81.6 MG / sodium phosphate, monobasic 40.8 MG / methylene blue 10.8 MG / hyoscyamine sulfate 0.12 MG Oral Tablet.
- RxCUI
- 1050325
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1050325 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Related concepts
- methenamine 81.6 MG (SCDC, consists of)
- methylene blue 10.8 MG (SCDC, consists of)
- sodium phosphate, monobasic 40.8 MG (SCDC, consists of)
- hyoscyamine sulfate 0.12 MG (SCDC, consists of)
- Oral Tablet (DF, has dose form)
- hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet [Urogesic Blue Reformulated Apr 2012] (SBD, has tradename)
- hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet [Uro-Blue] (SBD, has tradename)
Linked data
NDCs
- 49963051801
- 58657045401
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1050325 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1050325 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1050325. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.